Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients
Yibiao Chen,Jianda Sun,Dan Hu,Jian Zhang,Yuyun Xu,Huiting Feng,Zhijie Chen,Yi Luo,Yunlong Lou,Heming Wu
DOI: https://doi.org/10.2147/CMAR.S338394
2021-11-23
Cancer Management and Research
Abstract:Yibiao Chen, 1, 2 Jianda Sun, 1, 2 Dan Hu, 1, 2 Jian Zhang, 1, 2 Yuyun Xu, 1, 2 Huiting Feng, 1, 2 Zhijie Chen, 1, 2 Yi Luo, 1, 2 Yunlong Lou, 2, 3 Heming Wu 2, 4 1 Department of Radiation Oncology, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China; 2 Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China; 3 Department of Nuclear Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China; 4 Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China Correspondence: Yunlong Lou; Heming Wu Meizhou People's Hospital (Huangtang Hospital), No. 63 Huangtang Road, Meijiang District, Meizhou, 514031, People's Republic of China Tel +86 753-2131-591 Email ; Objective: The present study aimed to investigate the predictive value of some indexes, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic inflammatory response index (SIRI), and systemic immune-inflammatory index (SII) in the survival of nasopharyngeal carcinoma (NPC) and provide reference for the treatment. Methods: A retrospective analysis was performed on 216 patients from 2016 to 2018. The cutoff values of these indexes were determined by the receiver operating characteristic (ROC) curve. The prognostic value of the indexes was evaluated according to the rate of overall survival (OS), regional recurrence-free survival (RRFS), locoregional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS). Results: The survival analysis showed that NLR ≤ 2.695 (P = 0.017) and PLR ≤ 140.065 (P = 0.041) were associated with poor OS; however, the LMR and SIRI showed no significant statistical significance. NLR ≤ 2.045 (P = 0.018) and PLR ≤ 125.605 (P = 0.003) were associated with poor RRFS, LMR ≤ 2.535 (P = 0.027) and PLR ≤ 140.065 (P = 0.009) were associated with poor DMFS, NLR ≤ 2.125 (P = 0.018) and PLR ≤ 132.645 (P = 0.026) were associated with poor LRRFS, respectively. Logistic regression analysis showed that low LMR (≤ 2.535) was significantly inferior in OS (HR 23.085, 95% CI 3.425– 155.622, P = 0.001) and DMFS (HR 22.839, 95% CI 4.096– 127.343, P 70% of new cases were in Southeast Asia, with an age-standardised rate of 3.0 per 100,000 in China. 2 At present, radiotherapy is the main treatment for NPC, and with the promotion of comprehensive treatment, the treatment effect and prognosis of NPC patients have been significantly improved. However, due to individual patient differences, recurrence and metastasis remain the main causes of treatment failure for NPC. 3 To date, the prognosis of tumors, including NPC, is largely dependent on TNM stage. However, TNM staging is distinguished based on different anatomical structures and does not represent biological heterogeneity in NPC patients. 4 For NPC, it is necessary to find some meaningful prognostic biomarkers. Inflammatory response leads to chronic oxidative stress and production of oxygen-free radicals, which is closely related to the occurrence and development of cancer. 5 The detection of inflammatory markers in blood is convenient and low cost, which can be a prognostic reference index of NPC. At present, many inflammatory -Abstract Truncated-
oncology